FOR CIGNA, THE FUTURE OF SPECIALTY DRUG MANAGEMENT IS HERE
Specialty drugs are now the largest and fastest-growing segment of the U.S. pharmacy market and will continue to grow by 8% per year due to new specialty products coming to market, continued expansion of the specialty population, and the increasing costs of these medications. Employers need a Carrier with the flexibility to evolve solutions that address high-cost conditions. These types of large-scale challenges are what spark innovation at Cigna to offer solutions that confront the rising cost of specialty medications – and their impact on total medical costs for employees.
Cigna Pathwell Specialty addresses one of the top healthcare cost drivers – specialty medications – and allows Employers to reinvest in their employees, helping make healthcare more affordable. This new solution helps control specialty medication spending across the medical and pharmacy benefit, where specialty drugs are obtained and administered, and by coordinating care for customers who need support the most.
As their new standard specialty solution, Cigna Pathwell Specialty is made up of several components, including:
